Angiogenic and growth factors in gastric cancer

Journal of Surgical Research

Volumn 194, Issue 2, 2015, Pages 420-429

  Blank, Susanne ^a   Deck, Catrin ^a   Dreikhausen, Lena ^a   Weichert, Wilko ^b   Giese, Natalia ^a   Falk, Christine ^c   Schmidt, Thomas ^a   Ott, Katja ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Angiogenic factors; Gastric cancer; Growth factors; Prognosis; Response to chemotherapy

Indexed keywords

ANGIOPOIETIN 2; CAPECITABINE; CD31 ANTIGEN; CISPLATIN; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; FOLLISTATIN; GROWTH FACTOR; LEPTIN; OXALIPLATIN; TUMOR MARKER; VASCULOTROPIN; ANGIOGENIC PROTEIN; ANGPT2 PROTEIN, HUMAN; SIGNAL PEPTIDE; VASCULOTROPIN A;

ADULT; ANGIOGENESIS; ANTIANGIOGENIC THERAPY; ARTICLE; BLOOD; BLOOD LEVEL; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY; DIGESTIVE SYSTEM CANCER; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; STOMACH CANCER; TREATMENT RESPONSE; ADENOCARCINOMA; EPIDEMIOLOGY; GERMANY; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; STOMACH; STOMACH NEOPLASMS;

ADENOCARCINOMA; ANGIOGENIC PROTEINS; ANGIOPOIETIN-2; ANTIGENS, CD31; BIOMARKERS, TUMOR; FEMALE; FOLLISTATIN; GERMANY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; STOMACH; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84924860951     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.11.028     Document Type: Article

References (57)

1. R.T. Poon, S.T. Fan, and J. Wong Clinical implications of circulating angiogenic factors in cancer patients J Clin Oncol 19 2001 1207
2. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353
3. L. Holmgren, M.S. O'Reilly, and J. Folkman Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression Nat Med 1 1995 149
4. M.A. Shah, R.K. Ramanathan, and D.H. Ilson Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma J Clin Oncol 24 2006 5201
5. A. Ohtsu, M.A. Shah, and E. Van Cutsem Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study J Clin Oncol 29 2011 3968
6. C.S. Fuchs, J. Tomasek, and C.J. Yong Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial Lancet 383 2014 31
7. E. Van Cutsem, S. de Haas, and Y.K. Kang Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial J Clin Oncol 30 2012 2119
8. R.S. Herbst, D. Hong, and L. Chap Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors J Clin Oncol 27 2009 3557
9. A.C. Mita, C.H. Takimoto, and M. Mita Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors Clin Cancer Res 16 2010 3044
10. M.M. Eatock, N.C. Tebbutt, and C.L. Bampton Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer Ann Oncol 24 2013 710
11. D. Cunningham, W. Allum, and S. Stenning Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 2006 11
12. M. Ychou, V. Boige, and J.P. Pignon Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol 29 2011 1715
13. K. Becker, D. Reim, and A. Novotny Proposal for a multifactorial prognostic score that accurately classifies 3 groups of gastric carcinoma patients with different outcomes after neoadjuvant chemotherapy and surgery Ann Surg 256 2012 1002
14. A.F. Okines, R.E. Langley, and L.C. Thompson Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report Ann Oncol 24 2013 702
15. A.J. Karayiannakis, K.N. Syrigos, and A. Polychronidis Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery Ann Surg 236 2002 37
16. E. Lieto, F. Ferraraccio, and M. Orditura Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients Ann Surg Oncol 15 2008 69
17. Y. Kolev, H. Uetake, S. Iida, T. Ishikawa, T. Kawano, and K. Sugihara Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma Ann Surg Oncol 14 2007 2738
18. T. Etoh, H. Inoue, S. Tanaka, G.F. Barnard, S. Kitano, and M. Mori Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases Cancer Res 61 2001 2145
19. J. Wang, K. Wu, and D. Zhang Expressions and clinical significances of angiopoietin-1,-2 and Tie2 in human gastric cancer Biochem Biophys Res Commun 337 2005 386
20. W.S. Moon, H.S. Park, and K.H. Yu Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis J Korean Med Sci 21 2006 272
21. M.J. Jo, J.H. Lee, and B.H. Nam Preoperative serum angiopoietin-2 levels correlate with lymph node status in patients with early gastric cancer Ann Surg Oncol 16 2009 2052
22. X.D. Sun, X.E. Liu, J.M. Wu, X.J. Cai, Y.P. Mou, and J.D. Li Expression and significance of angiopoietin-2 in gastric cancer World J Gastroenterol 10 2004 1382
23. W. Kang, M. Saqui-Salces, Y. Zavros, and J.L. Merchant Induction of follistatin precedes gastric transformation in gastrin deficient mice Biochem Biophys Res Commun 376 2008 573
24. H. Kim, J.W. Eun, H. Lee, S.W. Nam, H. Rhee, and K.H. Koh Gene expression changes in patient-matched gastric normal mucosa, adenomas, and carcinomas Exp Mol Pathol 90 2011 201
25. F.F. Bolukbas, H. Kilic, and C. Bolukbas Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study BMC Cancer 4 2004 29
26. X. Zhao, K. Huang, Z. Zhu, S. Chen, and R. Hu Correlation between expression of leptin and clinicopathological features and prognosis in patients with gastric cancer J Gastroenterol Hepatol 22 2007 1317
27. S.J. Hong, K.W. Kwon, and S.G. Kim Variation in expression of gastric leptin according to differentiation and growth pattern in gastric adenocarcinoma Cytokine 33 2006 66
28. Y. Geng, J. Wang, and R. Wang Leptin and HER-2 are associated with gastric cancer progression and prognosis of patients Biomed Pharmacother 66 2012 419
29. L.G. Capelle, A.C. de Vries, and J. Haringsma Serum levels of leptin as marker for patients at high risk of gastric cancer Helicobacter 14 2009 596
30. D. Ribatti, D. Guidolin, and A. Marzullo Mast cells and angiogenesis in gastric carcinoma Int J Exp Pathol 91 2010 350
31. D. Yamac, T. Ayyildiz, and U. Coşkun Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma Pathol Res Pract 204 2008 527
32. U. Heger, F. Bader, and F. Lordick Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosis Gastric Cancer 17 2014 478
33. S. Blank, H. Bläker, and A. Schaible Impact of pretherapeutic routine clinical staging for the individualization of treatment in gastric cancer patients Langenbecks Arch Surg 397 2012 45
34. K. Ott, A. Sendler, and K. Becker Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study Gastric Cancer 6 2003 159
35. L.H. Sobin, and C.C. Compton TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer Cancer 116 2010 5336
36. K. Becker, R. Langer, and D. Reim Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases Ann Surg 253 2011 934
37. K. Becker, J. Mueller, and C. Schulmacher Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy Cancer 98 2003 1521
38. L. Peng, P. Zhan, and Y. Zhou Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis Mol Biol Rep 39 2012 9473
39. S. Sabbioni, E. Miotto, and A. Veronese Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood Mol Diagn 7 2003 201
40. U. Fiedler, Y. Reiss, and M. Scharpfenecker Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation Nat Med 12 2006 235
41. M. Scharpfenecker, U. Fiedler, Y. Reiss, and H.G. Augustin The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism J Cell Sci 118 Pt 4 2005 771
42. M. Felcht, R. Luck, and A. Schering Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling J Clin Invest 122 2012 1991
43. Y. Kienast, C. Klein, and W. Scheuer Ang-2-VEGF-A CrossMab, a novel bispecific human IgG1 antibody blocking VEGF-A and Ang-2 functions simultaneously, mediates potent antitumor, antiangiogenic, and antimetastatic efficacy Clin Cancer Res 19 2013 6730
44. L. Liu, X.L. Ma, Z.L. Xiao, M. Li, S.H. Cheng, and Y.Q. Wei Prognostic value of vascular endothelial growth factor expression in resected gastric cancer Asian Pac J Cancer Prev 13 2012 3089
45. Y. Kakeji, T. Koga, and Y. Sumiyoshi Clinical significance of vascular endothelial growth factor expression in gastric cancer J Exp Clin Cancer Res 21 2002 125
46. R.T. Gray, M.E. O'Donnell, J.A. McGuigan, and G.M. Spence Quantification of tumour and circulating vascular endothelial growth factor (VEGF) in patients with oesophagogastric cancer: a long-term follow-up study Br J Biomed Sci 69 2012 71
47. dJ. Park, C. Yoon, and N. Thomas Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers Ann Surg Oncol 21 2014 1130
48. H. Wilke, K. Muro, and E. Van Cutsem Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial Lancet Oncol 15 2014 1224
49. A. Darom, I.P. Gomatos, and E. Leandros Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients World J Gastroenterol 12 2006 1924
50. S. Park, T.A. DiMaio, E.A. Scheef, C.M. Sorenson, and N. Sheibani PECAM-1 regulates proangiogenic properties of endothelial cells through modulation of cell-cell and cell-matrix interactions Am J Physiol, Cell Physiol 299 2010 C1468
51. D. Gratzinger, M. Barreuther, and J.A. Madri Platelet-endothelial cell adhesion molecule-1 modulates endothelial migration through its immunoreceptor tyrosine-based inhibitory motif Biochem Biophys Res Commun 301 2003 243
52. R. Pai, C. Lin, T. Tran, and A. Tarnawski Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation Biochem Biophys Res Commun 331 2005 984
53. L. Zhao, Z.X. Shen, H.S. Luo, and L. Shen Possible involvement of leptin and leptin receptor in developing gastric adenocarcinoma World J Gastroenterol 11 2005 7666
54. M. Ishikawa, J. Kitayama, and H. Nagawa Expression pattern of leptin and leptin receptor (OB-R) in human gastric cancer World J Gastroenterol 12 2006 5517
55. K.N. Lee, H.S. Choi, and S.Y. Yang The role of leptin in gastric cancer: clinicopathologic features and molecular mechanisms Biochem Biophys Res Commun 446 2014 822
56. G.H. Bain, E. Collie-Duguid, and G.I. Murray Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas Br J Cancer 110 2014 1525
57. P. Villarejo-Campos, D. Padilla-Valverde, and R.M. Martin Serum VEGF and VEGF-C values before surgery and after postoperative treatment in gastric cancer Clin Transl Oncol 15 2013 265